X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (841) 841
clorgyline - pharmacology (825) 825
rats (611) 611
male (597) 597
monoamine oxidase inhibitors - pharmacology (434) 434
monoamine oxidase - metabolism (394) 394
selegiline - pharmacology (349) 349
clorgyline (280) 280
pharmacology & pharmacy (201) 201
kinetics (199) 199
rats, inbred strains (187) 187
in vitro techniques (168) 168
neurosciences (168) 168
humans (167) 167
serotonin - metabolism (167) 167
brain - enzymology (159) 159
monoamine oxidase (157) 157
female (155) 155
mice (124) 124
propylamines - pharmacology (119) 119
dopamine - metabolism (116) 116
pargyline - pharmacology (114) 114
rats, sprague-dawley (95) 95
brain - metabolism (94) 94
dopamine (93) 93
brain - drug effects (90) 90
serotonin (90) 90
dose-response relationship, drug (89) 89
brain (84) 84
monoamine oxidase inhibitors (83) 83
deprenyl (81) 81
phenethylamines - pharmacology (81) 81
norepinephrine - metabolism (80) 80
substrate specificity (78) 78
mitochondria - enzymology (73) 73
biochemistry & molecular biology (71) 71
time factors (71) 71
motor activity - drug effects (69) 69
index medicus (60) 60
antidepressive agents - pharmacology (58) 58
corpus striatum - metabolism (58) 58
liver - enzymology (55) 55
isoenzymes - metabolism (53) 53
mitochondria, liver - enzymology (53) 53
drug interactions (51) 51
rats, wistar (51) 51
corpus striatum - drug effects (48) 48
phenethylamines - metabolism (47) 47
rat (47) 47
tranylcypromine - pharmacology (45) 45
tyramine - metabolism (45) 45
deamination (43) 43
hydroxyindoleacetic acid - metabolism (43) 43
metabolism (43) 43
behavior, animal - drug effects (42) 42
monoamine-oxidase (42) 42
psychiatry (42) 42
desipramine - pharmacology (41) 41
monoamine oxidase - analysis (40) 40
pargyline (40) 40
moclobemide (39) 39
3,4-dihydroxyphenylacetic acid - metabolism (38) 38
oxidation-reduction (36) 36
parkinsons-disease (34) 34
benzylamines - metabolism (33) 33
blood pressure - drug effects (33) 33
cerebral cortex - metabolism (32) 32
clorgyline - administration & dosage (32) 32
rat-brain (32) 32
selegiline (32) 32
brain chemistry - drug effects (31) 31
microdialysis (31) 31
neurons - drug effects (31) 31
semicarbazides - pharmacology (31) 31
adult (30) 30
middle aged (30) 30
antidepressants (29) 29
binding sites (29) 29
norepinephrine (29) 29
reserpine - pharmacology (29) 29
striatum (29) 29
cerebral cortex - drug effects (28) 28
circadian rhythm - drug effects (28) 28
mao-a (28) 28
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (27) 27
depression (27) 27
monoamine oxidase - genetics (27) 27
myocardium - enzymology (27) 27
piperidines - pharmacology (27) 27
amine oxidase (26) 26
mitochondria - drug effects (26) 26
neurons (26) 26
receptors (26) 26
receptors, serotonin - drug effects (26) 26
tissue distribution (26) 26
binding (25) 25
clorgyline - therapeutic use (25) 25
drug synergism (25) 25
isoenzymes - antagonists & inhibitors (25) 25
chromatography, high pressure liquid (24) 24
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (984) 984
Russian (19) 19
French (2) 2
German (2) 2
Japanese (2) 2
Spanish (2) 2
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuroendocrinology Letters, ISSN 0172-780X, 2010, Volume 31, Issue 5, pp. 645 - 656
Journal Article
Psychopharmacology, ISSN 0033-3158, 8/2016, Volume 233, Issue 15, pp. 2955 - 2971
Fas-associated death domain (FADD) is an adaptor of death receptors that can also induce anti-apoptotic actions through its phosphorylated form (p-FADD).... 
Neuroplasticity | Neuroprotection | Neurosciences | Biomedicine | FADD and p-FADD | Forced swim test | Anti-depressant drugs | Pharmacology/Toxicology | Psychiatry | Electroconvulsive shock | PRESYNAPTIC AUTORECEPTORS | NEUROTRANSMITTER RELEASE | PSYCHIATRY | ANTIDEPRESSANT TREATMENT | ADRENERGIC-RECEPTOR | MAJOR DEPRESSION | SUICIDE VICTIMS | NEUROSCIENCES | PREFRONTAL CORTEX | MONOAMINE-OXIDASE INHIBITORS | PHARMACOLOGY & PHARMACY | GAMMA-AMINOBUTYRIC-ACID | DEATH DOMAIN PROTEIN | Phosphoproteins - drug effects | Phenelzine - pharmacology | Autoreceptors - metabolism | Clorgyline - pharmacology | Male | Adrenergic alpha-Antagonists - pharmacology | Phosphoproteins - metabolism | Cerebral Cortex - metabolism | Idazoxan - pharmacology | Mianserin - analogs & derivatives | Mianserin - pharmacology | Desipramine - pharmacology | Fluoxetine - analogs & derivatives | Mirtazapine | Antidepressive Agents - pharmacology | Cerebral Cortex - drug effects | Phosphorylation - drug effects | RNA-Binding Proteins - antagonists & inhibitors | Fluoxetine - pharmacology | Idazoxan - analogs & derivatives | Monoamine Oxidase Inhibitors - pharmacology | Fas-Associated Death Domain Protein - drug effects | Norepinephrine Plasma Membrane Transport Proteins - antagonists & inhibitors | Fas-Associated Death Domain Protein - metabolism | Rats | Excitatory Amino Acid Antagonists - pharmacology | Blotting, Western | Brain - drug effects | Animals | CASP8 and FADD-Like Apoptosis Regulating Protein | Thiazoles - pharmacology | Ketamine - pharmacology | Electroshock | Apoptosis | Indans - pharmacology | Pharmacology, Experimental | Antidepressants | Desipramine | Fluoxetine | Psychopharmacology | Dosage and administration | Research | Proteins | Brain | Rodents
Journal Article
Psychopharmacology, ISSN 0033-3158, 12/2008, Volume 201, Issue 2, pp. 203 - 218
Serotonin transporter (SERT) knockout (−/−) mice have an altered phenotype in adulthood, including high baseline anxiety and depressive-like behaviors,... 
Neurosciences | Temperature | SB 269970 | 8-hydroxy-2-(di- n -propylamino)tetralin (8-OH-DPAT) | High-performance liquid chromatography (HPLC) | Dopamine transporter (DAT) | N -[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- N -2-pyridinylcyclohexanecarboxamide maleate salt (WAY 100635) | Biomedicine | GBR 12909 | 5-hydroxy-L-tryptophan (5-HTP) | 5-carboxamidotryptamine maleate (5-CT) | Pharmacology/Toxicology | Serotonin syndrome behaviors | Psychiatry | 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) | KNOCK-OUT MICE | EARLY-LIFE BLOCKADE | PSYCHIATRY | N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinylcyclohexanecarboxamide maleate salt (WAY 100635) | 5-HT7 RECEPTOR ANTAGONIST | DEFICIENT MICE | NEUROSCIENCES | 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN 8-OH-DPAT | TARGETED DISRUPTION | HYPOTHERMIC RESPONSE | PHARMACOLOGY & PHARMACY | POSTNATAL-DEVELOPMENT | RAT-BRAIN | REUPTAKE INHIBITOR | Brain Chemistry - drug effects | Brain - anatomy & histology | Clorgyline - pharmacology | Serotonin Plasma Membrane Transport Proteins - deficiency | Male | Piperazines - toxicity | 5-Hydroxytryptophan - pharmacology | Hypothermia - chemically induced | Serotonin - pharmacology | Serotonin Receptor Agonists - pharmacology | Brain - metabolism | Serotonin Plasma Membrane Transport Proteins - genetics | Tranylcypromine - pharmacology | Female | Drug Therapy, Combination | Phenols - pharmacology | Monoamine Oxidase Inhibitors - pharmacology | Dopamine Uptake Inhibitors - pharmacology | Hydroxyindoleacetic Acid - metabolism | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Hydroxyindoleacetic Acid - analysis | Sulfonamides - pharmacology | Piperazines - pharmacology | Mice, Knockout | Brain - drug effects | Drug Synergism | Serotonin Syndrome - chemically induced | Catecholamines - antagonists & inhibitors | Animals | Catecholamines - classification | Serotonin - metabolism | Serotonin - analogs & derivatives | Mice | Pyridines - pharmacology | Serotonin 5-HT1 Receptor Antagonists | Amino acids | Neurotransmitters | Animal behavior | Psychopharmacology | Rodents | Index Medicus
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2007, Volume 30, Issue 9, pp. 1758 - 1762
Journal Article
Journal Article
Psychopharmacology, ISSN 0033-3158, 11/2008, Volume 201, Issue 1, pp. 55 - 66
The hallucinogenic tea known as ayahuasca is made from a combination of psychoactive plants that contribute the active components N,N-dimethyltryptamine (DMT)... 
5-methoxydimethyltryptamine | Harmaline | Neurosciences | Biomedicine | Serotonin | Ayahuasca | Hallucinogen | Pharmacology/Toxicology | Psychiatry | MAOI | SEROTONIN RECEPTOR | BETA-CARBOLINES | PSYCHIATRY | PROPOSED ANIMAL-MODEL | HALLUCINOGENIC DRUG-INTERACTIONS | NEUROSCIENCES | DIFFERENTIAL INTERACTIONS | PSYCHOTOMIMETIC AMINE | 5-HT2 RECEPTORS | STIMULUS-CONTROL | INVIVO METABOLISM | PHARMACOLOGY & PHARMACY | LSD | Clorgyline - pharmacology | Motor Activity - drug effects | Male | Behavior, Animal | Dose-Response Relationship, Drug | Methoxydimethyltryptamines - chemistry | 2,5-Dimethoxy-4-Methylamphetamine - pharmacology | Drug Interactions | Pharmaceutical Vehicles - chemistry | Piperidines - pharmacology | Time Factors | Psychotropic Drugs - pharmacology | Exploratory Behavior - drug effects | Hyperkinesis - chemically induced | Methoxydimethyltryptamines - pharmacology | Receptor, Serotonin, 5-HT2A - drug effects | Drug Therapy, Combination | Harmaline - pharmacology | Monoamine Oxidase Inhibitors - pharmacology | Drug Administration Schedule | Rats | Pharmaceutical Vehicles - administration & dosage | Psychotropic Drugs - chemistry | Piperazines - pharmacology | Rats, Sprague-Dawley | Receptor, Serotonin, 5-HT2A - physiology | Animals | Behavioral Research - instrumentation | Pyridines - pharmacology | Pattern Recognition, Automated | Serotonin 5-HT1 Receptor Antagonists | Herbs | Tea | Pharmacology | Animal behavior | Hallucinogens | Rodents | Index Medicus | serotonin | hallucinogen | harmaline
Journal Article
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 11/2013, Volume 170, Issue 5, pp. 999 - 1013
Background and Purpose Selective MAO type B (MAO‐B) inhibitors are effective in potentiation of the clinical effect of L‐DOPA in Parkinson's disease, but... 
rasagiline | glial cells | L‐DOPA | Parkinson's disease | microdialysis | 6‐hydroxydopamine | medium spiny neurons | clorgyline | OCT‐3 | 6-hydroxydopamine | L-DOPA | OCT-3 | AMINO-ACID DECARBOXYLASE | 6-HYDROXYDOPAMINE-TREATED RATS | EXTRACELLULAR DOPAMINE | ANIMAL RESEARCH | TYROSINE-HYDROXYLASE | ARRIVE GUIDELINES | SUBSTANTIA-NIGRA | EXOGENOUS L-DOPA | MONOAMINE-OXIDASE-A | IN-VIVO | PHARMACOLOGY & PHARMACY | Antiparkinson Agents - pharmacology | Organic Anion Transporters, Sodium-Independent - antagonists & inhibitors | Clorgyline - pharmacology | Male | Glial Fibrillary Acidic Protein - metabolism | Serotonergic Neurons - metabolism | Dopamine Agents - pharmacology | Organic Anion Transporters, Sodium-Independent - metabolism | Dopaminergic Neurons - metabolism | Dopaminergic Neurons - drug effects | Dopamine - metabolism | Levodopa - pharmacology | Monoamine Oxidase Inhibitors - pharmacology | Serotonergic Neurons - drug effects | Rats | 5,7-Dihydroxytryptamine - toxicity | Basal Ganglia - enzymology | Rats, Sprague-Dawley | Oxidopamine - toxicity | Animals | Microdialysis | Fluorescent Antibody Technique | Basal Ganglia - drug effects | Indans - pharmacology | Monoamine Oxidase - metabolism | Phenols | Monoamine oxidase | Serotonin | Antiparkinsonian agents | Brain | Rodents | Dopamine | Research Papers
Journal Article
Journal Article
Psychopharmacology, ISSN 0033-3158, 11/2007, Volume 195, Issue 1, pp. 117 - 124
Many pregnant women continue to smoke, despite a strong association between maternal smoking and neurobehavioral deficits in the offspring. Although... 
Adolescence | Tobacco | Biomedicine | Dopamine | Deprenyl | Fetal | Sensitization | Pharmacology/Toxicology | Psychiatry | Clorgyline | Maternal smoking | deprenyl | PRENATAL EXPOSURE | PSYCHIATRY | BEHAVIORAL SENSITIZATION | ADULT-RATS | MOTIVATION | fetal | NEUROSCIENCES | PREGNANCY | CIGARETTE-SMOKING | PERIADOLESCENT | adolescence | PHARMACOLOGY & PHARMACY | tobacco | MICE | sensitization | maternal smoking | dopamine | BRAIN | clorgyline | Nicotine - administration & dosage | Prenatal Exposure Delayed Effects | Age Factors | Clorgyline - pharmacology | Selegiline - pharmacology | Motor Activity - drug effects | Monoamine Oxidase Inhibitors - administration & dosage | Nicotine - pharmacology | Dose-Response Relationship, Drug | Drug Interactions | Time Factors | Behavior, Animal - drug effects | Female | Clorgyline - administration & dosage | Nicotinic Agonists - pharmacology | Animals, Newborn | Vasoconstrictor Agents - pharmacology | Monoamine Oxidase Inhibitors - pharmacology | Vasoconstrictor Agents - administration & dosage | Infusion Pumps, Implantable | Injections, Intraperitoneal | Rats | Factor Analysis, Statistical | Rats, Sprague-Dawley | Pregnancy | Cocaine - administration & dosage | Cocaine - pharmacology | Nicotinic Agonists - administration & dosage | Animals | Selegiline - administration & dosage | Sensory Thresholds - drug effects | Rodents | Motor ability | Pharmacology | Models | Cocaine | Experimental psychology | Nicotine
Journal Article
ChemMedChem, ISSN 1860-7179, 07/2016, Volume 11, Issue 14, pp. 1551 - 1567
Journal Article
14.